Showing results (1601-1610 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|March 31, 2025
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2Cathy Eng, Arvind Dasari, Sara Lonardi, et al.
The Oncologist|March 31, 2025
Unmet need for previously untreated metastatic triple-negative breast cancer: a real-world study of patients diagnosed from 2011 to 2022 in the United StatesKevin Punie, Allison W Kurian, Ioanna Ntalla, et al.
The Oncologist|June 19, 2025
Oligometastatic pancreatic cancer: current state of management and emerging therapiesAndrii Khomiak, Nicole B Balmaceda, Sumaya A Ghaffar, et al.
The Oncologist|June 17, 2025
Efficacy and safety of regorafenib plus biweekly trifluridine/tipiracil for refractory metastatic colorectal cancer: a multicenter single-arm phase II trialXiangling Wang, Zhen Li, Dan Sha, et al.
The Oncologist|June 14, 2025
Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based studyCamille Evrard, Antoine Pelras, Simon Rivet, et al.
The Oncologist|June 2, 2025
Postoperative adjuvant chemotherapy and chemoimmunotherapy after radical resection for biliary tract cancer: a retrospective studyYuhuai Peng, Guoyi Xia, Yufeng Li, et al.
The Oncologist|May 27, 2025
Thoracic SMARCA4-deficient undifferentiated tumor: diagnostic characteristics, molecular insights, and treatment approachesJunmin Song, Adam Gersten, Benjamin Herzberg, et al.
The Oncologist|May 27, 2025
Biweekly dosing of trifluridine-tipiracil reduces rates of myelosuppression while maintaining efficacy in patients with metastatic colorectal cancerChristopher Cann, Michael LaPelusa, Sarah Cimino, et al.
The Oncologist|May 27, 2025
Concordance with SPIRIT-AI guidelines in reporting of randomized controlled trial protocols investigating artificial intelligence in oncology: a systematic reviewDavid Chen, Emily He, Keiran Pace, et al.
The Oncologist|May 14, 2025
Decoding NATALEE and MonarchE eligibility criteria in a real-world cohort of early breast cancer patientsJacopo Canzian, Damiano Gentile, Rita De Sanctis, et al.
Pageof 571